(Q43561419)

24 November 2017

0 references

Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status (English)

1 reference

24 November 2017

Jakob Linseisen

5

0 references

Dieter Flesch-Janys

series ordinal

6

object named as

Dieter Flesch-Janys

1 reference

24 November 2017

7

Rudolf Kaaks

1 reference

24 November 2017

8

Jenny Chang-Claude

1 reference

24 November 2017

2

Alina Vrieling

1 reference

24 November 2017

3

Katharina Buck

1 reference

PubMed ID

21544804

24 November 2017

Aida Karina Zaineddin

series ordinal

1

object named as

Aida Karina Zaineddin

1 reference

24 November 2017

4

Susen Becker

1 reference

PubMed ID

21544804

24 November 2017

language of work or name

English

0 references

publication date

21 July 2011

1 reference

International Journal of Cancer

24 November 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 November 2017

130

1 reference

24 November 2017

6

1 reference

24 November 2017

1401-1410

1 reference

Recent diet and breast cancer risk: the California Teachers Study (USA).

24 November 2017

1 reference

Phytoestrogen intake and endometrial cancer risk

21 January 2018

1 reference

Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells

21 January 2018

1 reference

Phytoestrogens and breast cancer risk. Review of the epidemiological evidence

21 January 2018

1 reference

Phytoestrogen and breast cancer prevention

21 January 2018

1 reference

Phyto-oestrogens and Western diseases

21 January 2018

1 reference

Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study.

21 January 2018

1 reference

Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study

21 January 2018

1 reference

Use of oral antimicrobials decreases serum enterolactone concentration

21 January 2018

1 reference

Case-control study of phyto-oestrogens and breast cancer

21 January 2018

1 reference

Circulating enterolactone and risk of breast cancer: a prospective study in New York

21 January 2018

1 reference

Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know

21 January 2018

1 reference

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy

21 January 2018

1 reference

Time-resolved fluoroimmunoassay of plasma daidzein and genistein.

21 January 2018

1 reference

Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study

21 January 2018

1 reference

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study

21 January 2018

1 reference

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status

21 January 2018

1 reference

21 January 2018

Lignans and human health

1 reference

An incident case-referent study on plasma enterolactone and breast cancer risk

21 January 2018

1 reference

The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes.

21 January 2018

1 reference

Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence

21 January 2018

1 reference

Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study

21 January 2018

1 reference

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status

21 January 2018

1 reference

Meta-analyses of lignans and enterolignans in relation to breast cancer risk

21 January 2018

1 reference

Plasma enterolactone and genistein and the risk of premenopausal breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26157

1 reference

24 November 2017

1 reference

PubMed ID

21544804